References
- Hoffman, R. J. (2011). Methylxanthines and selective β2 adrenergic agonists. In: Nelson, L. S., Lewin, N. A., Howland, M. A., Hoffman, R. S., Goldfrank, L. R., Flomenbaum, N. E. (Eds.), Goldfrank’s toxicologic emergencies, 9th ed. (pp. 952–964). New York: McGraw-Hill.
- Liebelt, E. L. (2011). Cyclic antidepressants. In: Nelson, L. S., Lewin, N. A., Howland, M. A., Hoffman, R. S., Goldfrank, L. R., Flomenbaum, N. E. (Eds.), Goldfrank’s toxicologic emergencies, 9th ed. (pp. 1049–1049). New York: McGraw-Hill.
- Marshall, J. B., Forker, A. D. (1982). Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications. Am Heart J 103:401–414.
- Oransay, K., Kalkan, S., Hocaoglu, N., Arici, A., Tuncok Y. (2011). An alternative antidote therapy in amitriptyline-induced rat toxicity model: theophylline. Drug Chem Toxicol 34:53–60.